Medtronic Evolut™ EXPAND TAVR I Feasibility Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Josep Rodes-Cabau, MD
Fondation IUCPQ
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Alfred Hospital
Melbourne, Australia
- Iucpq
Québec, Canada
- Rabin Medical Center
Petah Tikva, Israel
- Waikato Hospital
Hamilton, New Zealand
- Los Robles Hospital & Medical Center
Thousand Oaks, California, United States
- Northwell Health
Manhasset, New York, United States
- Upmc Pinnacle Harrisburg Campus
Wormleysburg, Pennsylvania, United States
- Aurora Saint Luke'S Medical Center
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 May 2021
- Primary completion
- 7 Jun 2022
- Completion
- 7 Jun 2022
- Last update posted
- 10 Jan 2024
- Registered enrollment
- 11
- Registry id
- NCT04639258
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.